All News Hexima Limited

Equities

Delayed Australian Stock Exchange Other stock markets 07:04:34 2023-10-01 pm EDT			5-day change	1st Jan Change
0.0220 ^AUD	0.00%		0.00%	+10.00%

Sep. 19	Hexima Limited Appoints Phillip Hains as A Non-Executive Director	CI
Sep. 06	Hexima Limited Appoints Geoffrey Kempler as Managing Director	CI

Hexima Limited Appoints Phillip Hains as A Non-Executive Director	Sep. 18	CI
Hexima Limited Appoints Geoffrey Kempler as Managing Director	Sep. 05	CI
Hexima Limited Announces Executive Changes	Sep. 05	CI
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2023	Aug. 31	CI
Hexima Limited Announces Resignation of Mr. Steven Skala as an Alternate Director	May. 11	CI
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2022	Feb. 27	CI
Hexima Limited Declares Voting Results	Jan. 30	CI
Arovella Therapeutics Appoints COO	Jan. 03	MT
Hexima Acting CEO to Step Down	Dec. 22	MT
Nicole Van Der Weerden to Step Down as CEO of Hexima Limited	Dec. 22	CI
Hexima Receives AU$6 Million Tax Incentive Refund from Australian Taxation Office	Dec. 14	MT
Hexima Limited Receives Requisition Notice from Merchant Biotech Fund	Dec. 13	CI
Hexima Limited Announces Board Changes	Dec. 04	CI
10,150,000 Options of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	Nov. 30	CI
6,925,878 Ordinary Shares of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	Nov. 30	CI
Hexima : 2022 Annual Financial Report	2022	PU
Hexima Limited Announces Change of Address	2022	CI
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2022	2022	CI
Hexima Managing Director, CEO Steps Down	2022	MT
Hexima Limited Announces Management Changes	2022	CI

No results for this search